[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Gains As Market Dips: What You Should Know",
    "summary": "In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=415b57b139ce248a5707a6e35002e1ecbc2ceb88d28d13d34eac8df0cd1bb454",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741730408,
      "headline": "Boston Scientific (BSX) Gains As Market Dips: What You Should Know",
      "id": 133185384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=415b57b139ce248a5707a6e35002e1ecbc2ceb88d28d13d34eac8df0cd1bb454"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report",
    "summary": "Boston Scientific (NYSE:BSX) recently experienced a 4% increase in its share price in the past quarter, amid significant corporate developments. The departure announcement of board member Charles J. Dockendorff may have prompted some investor reassessment, coinciding with a period where no shares were repurchased, indicating a pause in capital return strategies. The earnings results released this quarter showed an increase in sales and net income, providing a potential boost to investor...",
    "url": "https://finnhub.io/api/news?id=6d047c7a84905ba2fdf267e52a3af865d013843b47d8217c6e9038d278cc4970",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741715482,
      "headline": "Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report",
      "id": 133185385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (NYSE:BSX) recently experienced a 4% increase in its share price in the past quarter, amid significant corporate developments. The departure announcement of board member Charles J. Dockendorff may have prompted some investor reassessment, coinciding with a period where no shares were repurchased, indicating a pause in capital return strategies. The earnings results released this quarter showed an increase in sales and net income, providing a potential boost to investor...",
      "url": "https://finnhub.io/api/news?id=6d047c7a84905ba2fdf267e52a3af865d013843b47d8217c6e9038d278cc4970"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8caa537900c366ff9c9dcc059799063674d8122459dc4d0ea50afd0d20a336d8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741710960,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 133152438,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8caa537900c366ff9c9dcc059799063674d8122459dc4d0ea50afd0d20a336d8"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings",
    "summary": "GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.",
    "url": "https://finnhub.io/api/news?id=932fbf5ae9ac78cd9291f4c0493844124fc0d06fdb57eff5f03dbdf4cc040445",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741710480,
      "headline": "GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings",
      "id": 133185386,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.",
      "url": "https://finnhub.io/api/news?id=932fbf5ae9ac78cd9291f4c0493844124fc0d06fdb57eff5f03dbdf4cc040445"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now",
    "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=fcd15d8bcb70801298124f0b71bdeb59898cab82139fc856aa2dacff030ec837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741710360,
      "headline": "Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now",
      "id": 133185387,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=fcd15d8bcb70801298124f0b71bdeb59898cab82139fc856aa2dacff030ec837"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?",
    "summary": "BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.",
    "url": "https://finnhub.io/api/news?id=bef64d500f6166328fb3d4fa60d92178a2eb77343b8a5400e9db9cb6259b4a29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741697040,
      "headline": "Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?",
      "id": 133185388,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.",
      "url": "https://finnhub.io/api/news?id=bef64d500f6166328fb3d4fa60d92178a2eb77343b8a5400e9db9cb6259b4a29"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Hold TNDM Stock in Your Portfolio for Now",
    "summary": "A robust product innovation and several strategic developments raise investors' optimism for Tandem Diabetes.",
    "url": "https://finnhub.io/api/news?id=50644b4e4803a4385c12357c591c37763bfe00aac3666105c5388eaf62b434df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741696920,
      "headline": "Reasons to Hold TNDM Stock in Your Portfolio for Now",
      "id": 133185389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "A robust product innovation and several strategic developments raise investors' optimism for Tandem Diabetes.",
      "url": "https://finnhub.io/api/news?id=50644b4e4803a4385c12357c591c37763bfe00aac3666105c5388eaf62b434df"
    }
  }
]